1. A multicenter, prospective, observational study examining the impact of risk factors, such as BMI and waist circumference, on quality of life improvement and clinical response in moderate‐to‐severe plaque‐type psoriasis patients treated with infliximab in routine care settings of Greece. (20th April 2018) Authors: Petridis, A.; Panagakis, P.; Moustou, E.; Vergou, T.; Kallidis, P.; Mandekou‐Lefaki, I.; Chaidemenos, G.; Sotiriadis, D.; Alexopoulou, G.; Haratsis, Y.; Antoniou, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 5(2018) Page Start: 768 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Real‐world data from a single Greek centre on the use of secukinumab in plaque psoriasis: effectiveness, safety, drug survival, and identification of patients that sustain optimal response. (28th February 2020) Authors: Rompoti, N.; Sidiropoulou, P.; Panagakis, P.; Stratigos, A.; Papoutsaki, M.; Stefanaki, E.; Vavouli, C.; Politou, M.; Befon, A.; Kostakis, P.; Rigopoulos, D.; Nicolaidou, E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 6(2020) Page Start: 1240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra‐patient, left‐to‐right prospective study. (6th May 2020) Authors: Gregoriou, S.; Sidiropoulou, P.; Tsimpidakis, A.; Rompoti, N.; Tsironi, T.; Panagakis, P.; Polydorou, D.; Kostakis, P.; Rigopoulos, D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 9(2020) Page Start: e519 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗